Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol for STEMI treated with primary PCI
ACTRN12624000409572Phase 2Not yet recruiting
- Sponsor
- Te Whatu Ora
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acetaminophen in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Te Whatu Ora. Primary endpoint: Peak troponin level. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
acetaminophen
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ACTRN12624000409572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000409572.